Kyverna Therapeutics (KYTX) Non Operating Interest Expenses (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Non Operating Interest Expenses of $674,000 for Q2 2026, compared with $14,000 a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Kyverna Therapeutics was $1.79 million; for FY2025, it came in at $489,000, up 244.4% from FY2024.
- In prior years, Kyverna Therapeutics' Non Operating Interest Expenses was $142,000 in FY2024 (-24.1%) and $187,000 in FY2023.
- The Q2 2026 figure stands as the highest quarterly Non Operating Interest Expenses in data going back to Q1 2023.
- According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $667,000 (Q1 2026), $444,000 (Q4 2025) and $7,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Kyverna Therapeutics | 418.68 Mn | 418.68 Mn | - | 674,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 674,000.00 |
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 44,000.00 |
API Access
Kyverna Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();